Ifosfamide

Back to search

Molecule Structure

Scientific Name

Ifosfamide

Description of the Drug

Ifosfamide is an alkylating and immunosuppressive agent used in chemotherapy for the treatment of cancers, including testicular cancer, ovarian cancer, cervical cancer, osteocarcinoma, bladder cancer, small cell lung cancer, and non-Hodgkin’s lymphoma.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB01181

Brand Name(s)

Ifex, Ifosfamide, Ifsofamide, Mitoxana

Company Owner(s)

Hikma Pharmaceuticals Usa Inc, Teva Pharmaceuticals Usa, Fresenius Kabi Usa Llc, Baxter Healthcare Corp, Mylan Laboratories Ltd

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
DNA NUCLEIC-ACID INHIBITOR CHEMBL2311221

Unichem Links

SureChEMBL SCHEMBL4885
PharmGKB PA449964
Human Metabolome Database HMDB0015312
WDI IFOSFAMID
DrugBank DB01181
PubChem: Thomson Pharma 14823762
PubChem 3690
Mcule MCULE-1480299331
LINCS LSM-5118
Nikkaji J599.677E J2.196B J26.476H J599.676G
BindingDB 189358
EPA CompTox Dashboard DTXSID7020760
DrugCentral 1421
Brenda 143769
ChemicalBook CB7489350
Guide to Pharmacology 7201
GSRS e46b62c3-128b-4464-a71f-36ad6464fb9b
rxnorm IFEX IFOSFAMIDE
KEGG Ligand C07047
ChEBI 5864